Nalu raises $65m funding for neurostimulation system expansion
Nalu Medical will use the proceeds from the round to continue product development, and scale operations.
04 January 2024
04 January 2024
Nalu Medical will use the proceeds from the round to continue product development, and scale operations.
The non-invasive VIO System can produce real-time, multispectral images of the skin within seconds.
Renovite BMP-2 is made from a synthetic nanoclay gel, designed to be safer and more effective than current bone graft materials.
A US court has granted the FTC's request to halt the acquisition due to concerns that it will promote anticompetitive practices.
Valeda, which is already CE-marked for use in Europe, could be introduced to the US market in mid-2024 if approved by the US Food and Drug Administration (FDA).
The single-use molecular in vitro diagnostic test can be used with both swab and saliva samples.
The Syantra DX Breast Cancer test aims to improve specificity and sensitivity in detecting breast cancer, at early stages.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
GlobalData's latest thematic report will help you to understand and identify the important themes that threaten to disrupt your business in 2024. Our 2024 theme map covers not only disruptive tech themes but also ESG, macroeconomic, and regulatory themes. Reading this report is the first step towards making better business decisions in 2024.
Give your business an edge with our leading industry insights.